Vertex Ends One Type 1 Diabetes Cell Therapy, Shifts Focus To Another

 
• By Joseph Haas
  
Embryonic stem cells , Cellular therapy , Regeneration , Disease treatment , 3d illustration - Illustration
Vertex continues its stem cell-based approach to type 1 diabetes
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Cell Therapies

More from Therapy Areas